Athletigen Company
Delivering world-class DNA analysis techology to optimize performance in elite athletes and develop precision products
Funding Status:
Seed
Industry:
P4 Medicine
Estimated Revenue:
$1M to $10M
Technology:
P4 Medicine
Acquisitions Number:
1
Headquarters:
Canada
Total Funding:
$1.6M
Last Funding Type:
Seed
Investor Type:
For Profit
Employee Number:
11-50
Investors Number:
3
Founded Date:
2014-03-01